Shareholders of Tandem Diabetes would probably like to forget the past six months even happened. The stock dropped 54.1% and ...

Natixis Advisors LLC grew its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 3.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 65,678 shares of the ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect. Tandem Diabetes beat analysts’ revenue expectations by 8.5% ...

Amundi increased its holdings in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 42.9% in the fourth ...

Tandem Diabetes Care, Inc. announced NEJM publication of positive results from Control-IQ+ AID technology pivotal trial in ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

Stifel Nicolaus analyst Mathew Blackman maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) today and set a price target ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

– Additional data presented at the 18th International Conference on Advanced Technologies & Treatments for Diabetes – Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...